Are Postbiotics the Long Sought-After Solution for a Leaky Gut?

Journal of Nutrition

Volumn 149, Issue 11, 2019, Pages 1873-1874

  Anderson, Rachel Claire ^a,b  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b RIDDET INSTITUTE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PROBIOTIC AGENT; TIGHT JUNCTION PROTEIN; TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE;

ARTIFICIAL MILK; CELIAC DISEASE; CROHN DISEASE; HUMAN; INFECTION SENSITIVITY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; NOTE; SUPERNATANT; VULNERABLE POPULATION; ANIMAL; INTESTINE FLORA; LIVER; MOUSE;

ANIMALS; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS REUTERI; LIPOPOLYSACCHARIDES; LIVER; MICE;

EID: 85074444928     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/nxz171     Document Type: Note

References (16)

1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11: 506-14.
2. Aguilar-Toalá JE, Garcia-Varela R, Garcia HS, Mata-Haro V, González-Córdova AF, Vallejo-Cordoba B, Hernández-Mendoza A. Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol 2018;75:105-14.
3. Zawistowska-Rojek A, Tyski S. Are probiotics really safe for humans? Pol J Microbiol 2018;67:251-8.
4. Cui Y, Qi S, Zhang W, Mao J, Tang R, Wang C, Liu J, Luo XM, Wang H, Lactobacillus reuteri ZJ617 culture supernatant attenuates acute liver injury induced in mice by lipopolysaccharide. J Nutr 2019;149:2046-55.
5. Sahin H, Trautwein C, Wasmuth HE. TLR4 stresses the liver. Gut 2012;61:1241-2.
6. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:416-22.
7. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124:3-20; quiz 1-2.
8. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev 2009;9:799-809.
9. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42:71-8.
10. Schmidt C. Mental health: thinking from the gut. Nature 2015;518: S12-5.
11. Le Huerou-Luron I, Blat S, Boudry G. Breast-v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev 2010;23:23-36.
12. Schreiber RA, Walker WA. The gastrointestinal barrier: antigen uptake and perinatal immunity. Ann Allergy 1988;61:3-12.
13. Parrish AR. The impact of aging on epithelial barriers. Tissue Barriers 2017;5:e1343172.
14. Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of Inflammation? Inflamm Intest Dis 2016;1:135-45.
15. Bron PA, Kleerebezem M, Brummer R-J, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107.
16. Gao J, Li Y, Wan Y, Hu T, Liu L, Yang S, Gong Z, Zeng Q, Wei Y, Yang W, et al. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Front Microbiol 2019;10:477.